Report Detail
Global Sunitinib Malate Market Insights, Forecast to 2025
- RnM3515206 |
- 11 June, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
The demand of sunitinib malate is increasing, and global advancement of technology and increasing prevalence of pancreatic cancer are the prime growth drivers of the global sunitinib malate market.
The global Sunitinib Malate market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Sunitinib Malate market based on company, product type, end user and key regions.
This report studies the global market size of Sunitinib Malate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sunitinib Malate in these regions.
This research report categorizes the global Sunitinib Malate market by top players/brands, region, type and end user. This report also studies the global Sunitinib Malate market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Topcarepharm
Njfirstpharm
J&K Scientific
Targetmol
Market size by Product
Purity: >99%
Purity: >98%
Purity: >97%
Market size by End User
Pancreatic Neuroendocrine Tumors
Kidney Cancer
Gastrointestinal stromal tumor
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Sunitinib Malate market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Sunitinib Malate market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Sunitinib Malate companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Sunitinib Malate submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Sunitinib Malate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Sunitinib Malate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Sunitinib Malate Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Sunitinib Malate Market Size Growth Rate by Product
- 1.4.2 Purity: >99%
- 1.4.3 Purity: >98%
- 1.4.4 Purity: >97%
- 1.5 Market by End User
- 1.5.1 Global Sunitinib Malate Market Size Growth Rate by End User
- 1.5.2 Pancreatic Neuroendocrine Tumors
- 1.5.3 Kidney Cancer
- 1.5.4 Gastrointestinal stromal tumor
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Sunitinib Malate Market Size
- 2.1.1 Global Sunitinib Malate Revenue 2014-2025
- 2.1.2 Global Sunitinib Malate Sales 2014-2025
- 2.2 Sunitinib Malate Growth Rate by Regions
- 2.2.1 Global Sunitinib Malate Sales by Regions
- 2.2.2 Global Sunitinib Malate Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Sunitinib Malate Sales by Manufacturers
- 3.1.1 Sunitinib Malate Sales by Manufacturers
- 3.1.2 Sunitinib Malate Sales Market Share by Manufacturers
- 3.1.3 Global Sunitinib Malate Market Concentration Ratio (CR5 and HHI)
- 3.2 Sunitinib Malate Revenue by Manufacturers
- 3.2.1 Sunitinib Malate Revenue by Manufacturers (2014-2019)
- 3.2.2 Sunitinib Malate Revenue Share by Manufacturers (2014-2019)
- 3.3 Sunitinib Malate Price by Manufacturers
- 3.4 Sunitinib Malate Manufacturing Base Distribution, Product Types
- 3.4.1 Sunitinib Malate Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Sunitinib Malate Product Type
- 3.4.3 Date of International Manufacturers Enter into Sunitinib Malate Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Sunitinib Malate Sales by Product
- 4.2 Global Sunitinib Malate Revenue by Product
- 4.3 Sunitinib Malate Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Sunitinib Malate Breakdown Data by End User
6 North America
- 6.1 North America Sunitinib Malate by Countries
- 6.1.1 North America Sunitinib Malate Sales by Countries
- 6.1.2 North America Sunitinib Malate Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Sunitinib Malate by Product
- 6.3 North America Sunitinib Malate by End User
7 Europe
- 7.1 Europe Sunitinib Malate by Countries
- 7.1.1 Europe Sunitinib Malate Sales by Countries
- 7.1.2 Europe Sunitinib Malate Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Sunitinib Malate by Product
- 7.3 Europe Sunitinib Malate by End User
8 Asia Pacific
- 8.1 Asia Pacific Sunitinib Malate by Countries
- 8.1.1 Asia Pacific Sunitinib Malate Sales by Countries
- 8.1.2 Asia Pacific Sunitinib Malate Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Sunitinib Malate by Product
- 8.3 Asia Pacific Sunitinib Malate by End User
9 Central & South America
- 9.1 Central & South America Sunitinib Malate by Countries
- 9.1.1 Central & South America Sunitinib Malate Sales by Countries
- 9.1.2 Central & South America Sunitinib Malate Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Sunitinib Malate by Product
- 9.3 Central & South America Sunitinib Malate by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Sunitinib Malate by Countries
- 10.1.1 Middle East and Africa Sunitinib Malate Sales by Countries
- 10.1.2 Middle East and Africa Sunitinib Malate Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Sunitinib Malate by Product
- 10.3 Middle East and Africa Sunitinib Malate by End User
11 Company Profiles
- 11.1 Pfizer
- 11.1.1 Pfizer Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Pfizer Sunitinib Malate Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Pfizer Sunitinib Malate Products Offered
- 11.1.5 Pfizer Recent Development
- 11.2 Topcarepharm
- 11.2.1 Topcarepharm Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Topcarepharm Sunitinib Malate Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Topcarepharm Sunitinib Malate Products Offered
- 11.2.5 Topcarepharm Recent Development
- 11.3 Njfirstpharm
- 11.3.1 Njfirstpharm Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Njfirstpharm Sunitinib Malate Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Njfirstpharm Sunitinib Malate Products Offered
- 11.3.5 Njfirstpharm Recent Development
- 11.4 J&K Scientific
- 11.4.1 J&K Scientific Company Details
- 11.4.2 Company Business Overview
- 11.4.3 J&K Scientific Sunitinib Malate Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 J&K Scientific Sunitinib Malate Products Offered
- 11.4.5 J&K Scientific Recent Development
- 11.5 Targetmol
- 11.5.1 Targetmol Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Targetmol Sunitinib Malate Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Targetmol Sunitinib Malate Products Offered
- 11.5.5 Targetmol Recent Development
12 Future Forecast
- 12.1 Sunitinib Malate Market Forecast by Regions
- 12.1.1 Global Sunitinib Malate Sales Forecast by Regions 2019-2025
- 12.1.2 Global Sunitinib Malate Revenue Forecast by Regions 2019-2025
- 12.2 Sunitinib Malate Market Forecast by Product
- 12.2.1 Global Sunitinib Malate Sales Forecast by Product 2019-2025
- 12.2.2 Global Sunitinib Malate Revenue Forecast by Product 2019-2025
- 12.3 Sunitinib Malate Market Forecast by End User
- 12.4 North America Sunitinib Malate Forecast
- 12.5 Europe Sunitinib Malate Forecast
- 12.6 Asia Pacific Sunitinib Malate Forecast
- 12.7 Central & South America Sunitinib Malate Forecast
- 12.8 Middle East and Africa Sunitinib Malate Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Sunitinib Malate Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Sunitinib Malate . Industry analysis & Market Report on Sunitinib Malate is a syndicated market report, published as Global Sunitinib Malate Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Sunitinib Malate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
